Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1996-11-19
1998-07-28
Berch, Mark L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
544271, 544272, A61K 3152, C07D47306
Patent
active
057863601
ABSTRACT:
A compound useful as an A.sub.1 adenosine receptor antagonist has the formula: ##STR1## wherein R.sub.1 is selected from the group consisting of C.sub.1 -C.sub.8 alkyl;
REFERENCES:
patent: 2887468 (1959-05-01), Leake et al.
patent: 3309271 (1967-03-01), Georges
patent: 3317533 (1967-05-01), De Ridder
patent: 3961060 (1976-06-01), Fuxe
patent: 4612315 (1986-09-01), Jacobson et al.
patent: 4696932 (1987-09-01), Jacobson et al.
patent: 4968672 (1990-11-01), Jacobson et al.
patent: 4971972 (1990-11-01), Doll et al.
patent: 5068236 (1991-11-01), Suzuki et al.
patent: 5208240 (1993-05-01), Peet et al.
patent: 5248770 (1993-09-01), Jacobson et al.
patent: 5296463 (1994-03-01), Lee et al.
patent: 5298508 (1994-03-01), Jacobson et al.
patent: 5340813 (1994-08-01), Klein et al.
patent: 5395836 (1995-03-01), Shimada et al.
patent: 5434150 (1995-07-01), Austel et al.
patent: 5447933 (1995-09-01), Suzuki et al.
patent: 5532368 (1996-07-01), Kufner-Muhl et al.
patent: 5543415 (1996-08-01), Suzuki et al.
patent: 5545627 (1996-08-01), Jacobson et al.
Muller et al., "7-Deaza-2-phenyladenines: Structure-Activity Relationships of Potent A.sub.1 Selective Adenosine Receptor Antagonists," J. Med Chem 33:2822-2828, 1990.
Jacobson et al, "Adenosine Receptors: Pharmacology, Structure-Activity Relationships, and Therapeutic Potential," Journal of Medicinal Chemistry, vol. 35, No. 3, pp. 407-422, 1992.
Neely et al., "A.sub.1 Adenosine Receptor Antagonists Block Ischemia-Reperfusion Injury of the Heart," AHA Scientific Publishing, vol. 94, No. 9, Aug. 23, 1996, pp. 1-6.
Jacobson et al., "A Functionalized Cogener Approach to Adenosine Receptor Antagonists: Amino Acid Conjugates of 1,3-Dipropylxanthine," Molecular Pharmacology, 29:126-133.
van Galen et al., "A Model for the Antagonist Binding Site on the Adenosine A.sub.1 Receptor, Based on Steric, Electrostatic, and Hydrophobic Properties," J. Med. Chem, 1990, 33:1708-1713.
Berch Mark L.
Link Technology Incorporated
LandOfFree
A1 adenosine receptor antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with A1 adenosine receptor antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and A1 adenosine receptor antagonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-23859